Colorectal cancer: The diagnosis and management of colorectal cancer
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/cg131
2 Notes on the scope of the guidance
NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover. The scope of this guideline is available – click on 'How this guidance was produced'.
Groups that are covered
-
Adults (18 years and older) with newly diagnosed adenocarcinoma of the colon.
-
Adults with newly diagnosed adenocarcinoma of the rectum.
-
Adults with relapsed adenocarcinoma of the colon.
-
Adults with relapsed adenocarcinoma of the rectum.
Groups that are not covered
-
Patients with anal cancer.
-
Children (younger than 18) with colorectal cancer.
-
Patients with primary or secondary lymphoma of the colon and rectum.
-
Patients with pure small cell carcinoma of the colon and rectum.
-
Patients with carcinoid tumours of the colon and rectum.
-
Patients with high grade neuroendocrine tumours of the colon and rectum.
-
Patients with adenocarcinoma with some neuroendocrine differentiation.
-
Patients with gastrointestinal stromal tumours (GIST) or sarcoma of the colon and rectum.
How this guideline was developed
NICE commissioned the National Collaborating Centre for Cancer to develop this guideline. The Centre established a Guideline Development Group (see appendix A), which reviewed the evidence and developed the recommendations. An independent Guideline Review Panel oversaw the development of the guideline (see appendix B).
There is more information about how NICE clinical guidelines are developed on the NICE website and in How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS.